NG
Naveen Gullapalli
About Naveen Gullapalli
Data last updated:
Naveen Gullapalli is a Whole-Time Director at Amgen Technology Private Limited (since 2025), Director at Amgen Global Technology India Private Limited (since 2025) and Director at Amgen Research India Private Limited (since 2025), and holds 2 more current directorships. The companies operate in Research & Development, Information Technology and Biotechnology. The largest current company by reported revenue is Amgen Technology Private Limited at ₹166 Cr (FY 2025). Earlier, Naveen Gullapalli was a Whole-Time Director at Novartis Healthcare Private Limited (2014–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 23 Apr 2025 | 2007 | ₹166 Cr (FY 2025) | Active | |
| Director | 15 May 2025 | 2024 | Active | ||
| Director | 15 May 2025 | 2024 | Active | ||
| Designated Partner | 29 Jun 2021 | 2021 | Active | ||
| Partner | 09 Jan 2019 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Whole-Time Director | 13 Jun 2014 | 1997 | ₹6,088 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Naveen Gullapalli
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Naveen Gullapalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Naveen Gullapalli
Naveen Gullapalli currently holds 5 directorships: Amgen Technology Private Limited (Whole-Time Director, since 23 Apr 2025, revenue βΉ166 Cr (FY 2025)); Amgen Global Technology India Private Limited (Director, since 15 May 2025); Amgen Research India Private Limited (Director, since 15 May 2025); La Vista Farm Llp (Designated Partner, since 29 Jun 2021); Gg Consulting Llp (Partner, since 09 Jan 2019).
Naveen Gullapalli was first appointed on 13 Jun 2014 as Whole-Time Director at Novartis Healthcare Private Limited. The most recent appointment on record is 15 May 2025 at Amgen Research India Private Limited.
Naveen Gullapalli held 1 earlier board appointment: Novartis Healthcare Private Limited (Whole-Time Director, 13 Jun 2014 to 29 May 2024).
The current boards of Naveen Gullapalli's companies include David Ewan Foulstone (Amgen Technology Private Limited), Mansi Jayantilal Malkan (Amgen Technology Private Limited), Mihir Kumar Ojha (Amgen Technology Private Limited), Ng Lian Eric Teck (Amgen Technology Private Limited), David Lucas (Amgen Global Technology India Private Limited), Lisa Katz Gruber (Amgen Global Technology India Private Limited), among others.